Pit-1 positive alpha-subunit positive nonfunctioning human pituitary adenomas: a dedifferentiated GH cell lineage?
- PMID: 11081207
- DOI: 10.1023/a:1009954409469
Pit-1 positive alpha-subunit positive nonfunctioning human pituitary adenomas: a dedifferentiated GH cell lineage?
Abstract
Pit-1 is a transcription factor which has been reported to regulate differentiation toward GH, PRL and TSH in the anterior pituitary glands. In the human pituitary adenomas, Pit-1 is highly expressed in GH secreting and TSH secreting adenomas as it can well be anticipated. Interestingly, human non-functioning pituitary adenomas also express Pit-1, especially it was expressed in all alpha SU positive nonfunctioning adenomas. The human anterior pituitary cells are special in comparison with rodents in a finding that alpha SU is frequently colocalized with GH. As alpha SU is the first hormone appearing during fetal development in the rodent pituitary glands, it may be postulated that alpha SU Pit-1 positive cells undergo differentiation in the GH cell lineage. From this background, this paper proposes that "alpha SU positive Pit-1 Positive" cells are the ones in the GH cell lineage, more specifically a dedifferentiated cell lineage toward alpha SU/GH/Pit-1.
Similar articles
-
Induction of GH, PRL, and TSH beta mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line.Cell Tissue Res. 2005 Nov;322(2):269-77. doi: 10.1007/s00441-005-0033-z. Epub 2005 Nov 3. Cell Tissue Res. 2005. PMID: 16133148
-
Pit-1 gene expression in human pituitary adenomas.Horm Res. 1997;47(4-6):251-8. doi: 10.1159/000185472. Horm Res. 1997. PMID: 9167960 Review.
-
Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.Clin Endocrinol (Oxf). 1996 Sep;45(3):263-72. doi: 10.1046/j.1365-2265.1996.00812.x. Clin Endocrinol (Oxf). 1996. PMID: 8949563
-
Immunohistochemical expression of PIT-1 protein in pituitary glands of human GRF transgenic mice: its relationship with hormonal expressions.Endocr J. 1993 Feb;40(1):133-9. doi: 10.1507/endocrj.40.133. Endocr J. 1993. PMID: 7951487
-
Molecular pathology of the pituitary. Development and functional differentiation of pituitary adenomas.Front Horm Res. 2004;32:20-33. doi: 10.1159/000079036. Front Horm Res. 2004. PMID: 15281338 Review.
Cited by
-
Immunonegative "null cell" adenomas and gonadotropin (Gn) subunit (SUs) immunopositive adenomas share frequent expression of multiple transcription factors.Endocr Pathol. 2006 Spring;17(1):35-43. doi: 10.1385/ep:17:1:35. Endocr Pathol. 2006. PMID: 16760578
-
Pathology, pathogenesis and therapy of growth hormone (GH)-producing pituitary adenomas: technical advances in histochemistry and their contribution.Acta Histochem Cytochem. 2009 Aug 29;42(4):95-104. doi: 10.1267/ahc.09004. Epub 2009 Aug 11. Acta Histochem Cytochem. 2009. PMID: 19759870 Free PMC article.
-
ACTH and alpha-subunit are co-expressed in rare human pituitary corticotroph cell adenomas proposed to originate from ACTH-committed early pituitary progenitor cells.Endocr Pathol. 2008 Spring;19(1):17-26. doi: 10.1007/s12022-008-9014-6. Endocr Pathol. 2008. PMID: 18228160
-
High-risk pituitary adenomas and strategies for predicting response to treatment.Hormones (Athens). 2022 Mar;21(1):1-14. doi: 10.1007/s42000-021-00333-y. Epub 2022 Jan 21. Hormones (Athens). 2022. PMID: 35061210 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials